1. Home
  2. CUB vs JSPR Comparison

CUB vs JSPR Comparison

Compare CUB & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUB
  • JSPR
  • Stock Information
  • Founded
  • CUB 2024
  • JSPR 2018
  • Country
  • CUB United States
  • JSPR United States
  • Employees
  • CUB N/A
  • JSPR 45
  • Industry
  • CUB
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CUB
  • JSPR Health Care
  • Exchange
  • CUB NYSE
  • JSPR Nasdaq
  • Market Cap
  • CUB 307.3M
  • JSPR 323.6M
  • IPO Year
  • CUB 2024
  • JSPR N/A
  • Fundamental
  • Price
  • CUB $10.09
  • JSPR $21.57
  • Analyst Decision
  • CUB
  • JSPR Strong Buy
  • Analyst Count
  • CUB 0
  • JSPR 11
  • Target Price
  • CUB N/A
  • JSPR $73.38
  • AVG Volume (30 Days)
  • CUB 60.5K
  • JSPR 181.9K
  • Earning Date
  • CUB 01-01-0001
  • JSPR 11-07-2024
  • Dividend Yield
  • CUB N/A
  • JSPR N/A
  • EPS Growth
  • CUB N/A
  • JSPR N/A
  • EPS
  • CUB N/A
  • JSPR N/A
  • Revenue
  • CUB N/A
  • JSPR N/A
  • Revenue This Year
  • CUB N/A
  • JSPR N/A
  • Revenue Next Year
  • CUB N/A
  • JSPR N/A
  • P/E Ratio
  • CUB N/A
  • JSPR N/A
  • Revenue Growth
  • CUB N/A
  • JSPR N/A
  • 52 Week Low
  • CUB $9.96
  • JSPR $5.00
  • 52 Week High
  • CUB $10.55
  • JSPR $31.01
  • Technical
  • Relative Strength Index (RSI)
  • CUB N/A
  • JSPR 48.67
  • Support Level
  • CUB N/A
  • JSPR $20.12
  • Resistance Level
  • CUB N/A
  • JSPR $23.11
  • Average True Range (ATR)
  • CUB 0.00
  • JSPR 1.77
  • MACD
  • CUB 0.00
  • JSPR -0.16
  • Stochastic Oscillator
  • CUB 0.00
  • JSPR 32.53

About CUB LIONHEART HOLDINGS

Lionheart Holdings is a blank check company.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: